| ID | Sequence | Length | GC content |
|---|---|---|---|
| UUGGCCCCUCGCGCGCCGGGACAGGGCCACAAAUGACUGCACCUGGGCU… | 3647 nt | 0.4299 | |
| UUGGCCCCUCGCGCGCCGGGACAGGGCCACAAAUGACUGCACCUGGGCU… | 3647 nt | 0.4297 | |
| ACUCUUCUGUUCCCAGGAGAAUCAGGGGAGUCGGCGCCGGAAGGGGCGG… | 3763 nt | 0.4294 | |
| ACUCUUCUGUUCCCAGGAGAAUCAGGGGAGUCGGCGCCGGAAGGGGCGG… | 3763 nt | 0.4297 |
Predicted to enable cysteine-type deubiquitinase activity and cysteine-type endopeptidase activity. Predicted to be involved in several processes, including G1/S transition of mitotic cell cycle; positive regulation of type I interferon-mediated signaling pathway; and protein K48-linked deubiquitination. Predicted to be located in perinuclear region of cytoplasm. Predicted to be active in cytosol and nucleus. [provided by Alliance of Genome Resources, Jul 2025]
A study in mice demonstrated that the USP29 was significantly up-regulated across seven brain regions in ethanol-naïve High Drinking in the Dark (HDID-1) mice compared to control mice, with a fold change range of 1.52–2.14, identifying it as a differentially expressed gene associated with a genetic predisposition for binge drinking [Ferguson et al. DOI:10.1007/S12035-018-1252-0].